Upgrade to SI Premium - Free Trial

Nautilus Biotechnology (NAUT)

0.90 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/3/26)

Latest Headlines

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms September 4, 2026 8:00 AM - StreetInsider Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: AH Bio Fund II, L.P. August 28, 2026 7:44 PM - SEC Filing Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: PERCEPTIVE ADVISORS LLC August 14, 2026 5:23 PM - SEC Filing Form 10-Q Nautilus Biotechnology, For: Jun 30 July 28, 2026 4:07 PM - SEC Filing Nautilus Biotechnology Reports Second Quarter 2026 Financial Results July 28, 2026 8:00 AM - StreetInsider Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 4c July 28, 2026 6:49 AM - StreetInsider Form 8-K Nautilus Biotechnology, For: Jul 28 July 28, 2026 6:03 AM - SEC Filing Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: AH Bio Fund II, L.P. June 30, 2026 5:13 PM - SEC Filing Form 4 Nautilus Biotechnology, For: Jun 18 Filed by: Posard Matthew L. June 22, 2026 4:14 PM - SEC Filing Form 4 Nautilus Biotechnology, For: Jun 18 Filed by: NAZEM FARZAD June 22, 2026 4:14 PM - SEC Filing Form 4 Nautilus Biotechnology, For: Jun 18 Filed by: Akinsanya Karen June 22, 2026 4:14 PM - SEC Filing Form 4 Nautilus Biotechnology, For: Jun 18 Filed by: McIlwain Matthew S June 22, 2026 4:14 PM - SEC Filing Form 4 Nautilus Biotechnology, For: Jun 18 Filed by: Epperly Melissa B, June 22, 2026 4:14 PM - SEC Filing Form 8-K Nautilus Biotechnology, For: Jun 17 June 18, 2026 4:06 PM - SEC Filing Full Article List